News | Remote Monitoring | March 11, 2022

Implicity Hosts US Research Competition for Free Access to Advanced AI-powered Cardiac Remote Monitoring Platform

Clinical and academic researchers can apply for one of three spots for free access to cardiac remote monitoring and ILR ECG Analyzer to support CRM research

Implicity

March 15, 2022 Implicity, a leader in AI-powered remote patient monitoring and cardiac data management solutions, today announced an invitation for US-based researchers who are looking to conduct a study in the field of Cardiac Rhythm Management to apply for free access to Implicity’s cardiac remote monitoring software, including the ILR ECG Analyzer & Advanced Research Tool. This is an opportunity for investigators to use highly-intelligent cardiac remote care & research solutions to support their studies for a minimum of one year, with support from Implicity’s team of data scientists and engineers.

“Research is at the heart of what we do at Implicity. Our solution is already the official remote monitoring platform of one of the largest research consortiums in Europe, our goal now is to support academic medical centers, physicians, and researchers in the US as we look to improve the treatment and diagnosis of cardiovascular diseases. We are excited to host this unique research competition, provide study support through our device-agnostic platform, and learn of the findings from these studies,” said Dr. Arnaud Rosier, CEO, and founder of Implicity.

Cardiac remote monitoring has already been shown to reduce the number of unnecessary emergency department visits and improve the time to diagnose clinical events. As the adoption of RM continues to grow, more studies will be needed to measure the ongoing impact of emerging technologies and new applications. From managing patient data content forms to organizing cross-device data, the Implicity platform is an effective tool that researchers can use to drive more efficient operations while also enabling scale.

Implicity’s research competition is open to physicians, medical interns, physician groups, academic facilities, PhDs, PhD students or other allied health professionals based in the United States, leading studies that involve remote monitoring data from cardiac implantable electronic devices (CIEDs), ILR ECG analysis, or other areas related to cardiac remote monitoring.

The deadline to apply is Tuesday May 10th, 2022. A panel of industry judges will make decisions shortly thereafter – the panel includes Prof. Jagmeet Singh (Boston, MA), Prof. Niraj Varma (Cleveland, OH/London, ENG) and Dr. Suneet Mittal (Paramus, NJ/New York City, NY).

Winners receive free access to Implicity’s AI-powered Cardiac Remote Monitoring platform and features, including the ILR ECG Analyzer and the Advanced Research Tool module, for a minimum of 12 months.

For more information, including application instructions and proposal requirements, visit: https://www.implicity.com/landing-page/research_contest/.


Related Content

News | Artificial Intelligence

Oct. 30, 2024 — HeartLung Technologies, a developer of AI tools for early detection of heart disease, lung cancer and ...

Home October 30, 2024
Home
News | Artificial Intelligence

Oct. 27, 2024 — Investigators from Gifu Heart Center and Fukuoka Sanno Hospital recently presented the results of the ...

Home October 29, 2024
Home
News | Artificial Intelligence

Oct. 14, 2024 – The Institute for AI Governance in Healthcare (IAIGH) has published the draft Healthcare AI Governance ...

Home October 15, 2024
Home
News | Artificial Intelligence

Oct. 2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London ...

Home October 04, 2024
Home
Videos | Artificial Intelligence

In DAIC's continuing Thought Leadership Series with Dr. Jeffrey Soble, a practicing cardiologist at Rush University ...

Home July 29, 2024
Home
News | Artificial Intelligence

July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution ...

Home July 25, 2024
Home
News | Artificial Intelligence

July 18, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, introduced ...

Home July 18, 2024
Home
News | Artificial Intelligence

July 18, 2024 — AliveCor, a global leader in AI-powered cardiology, today announced that the American Medical ...

Home July 18, 2024
Home
News | Artificial Intelligence

July 17, 2024 — HeartFlow, a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced ...

Home July 17, 2024
Home
News | Artificial Intelligence

July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company focused ...

Home July 11, 2024
Home
Subscribe Now